Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGP 7040

Known as: CGP-7040 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
  • S. Kawahara
  • Nihon rinsho. Japanese journal of clinical…
  • 1998
  • Corpus ID: 26549278
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to… Expand
Review
1994
Review
1994
The number of cases with tuberculosis is again increasing in many countries, and recently several nosocomial outbreaks of… Expand
1991
1991
The comparative activities of newer rifamycin analogs and the activity of rifabutin or rifapentine in combination with other… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Highly Cited
1990
Highly Cited
1990
Minimal inhibitory and bactericidal concentrations (MICs and MBCs) of rifampin (RMP), rifabutin (RBT), rifapentine (RPT), CGP… Expand
Highly Cited
1987
Highly Cited
1987
Comparisons were made of the in vitro activity of rifampicin, and the rifamycin derivatives, rifapentine, rifabutin, CGP 29861… Expand
1987
1987
The bactericidal activity of six new rifamycin derivatives--rifabutin (RBU), FCE 22250 (F22), rifapentine (RPE), CGP 29861 (C29… Expand